Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
11.57
+0.15 (1.31%)
Jun 24, 2026, 2:27 PM EDT - Market open
Replimune Group Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 122.95 | 111.12 | 74.46 | 146.59 | 105.95 | 182.52 |
Short-Term Investments | 146.19 | 372.69 | 346.21 | 436.8 | 289.71 | 293.78 |
Cash & Short-Term Investments | 269.14 | 483.8 | 420.67 | 583.39 | 395.66 | 476.3 |
Cash Growth | -49.84% | 15.01% | -27.89% | 47.45% | -16.93% | 182.58% |
Other Receivables | 2.96 | 3.73 | 4.92 | 2.94 | 3.06 | 2.95 |
Total Trade Receivables | 2.96 | 3.73 | 4.92 | 2.94 | 3.06 | 2.95 |
Other Current Assets | 8.26 | 8.35 | 8.08 | 6.28 | 5.27 | 4.49 |
Total Current Assets | 280.35 | 495.88 | 433.67 | 592.6 | 403.98 | 483.75 |
Net Property, Plant & Equipment | 50.33 | 52.55 | 52.36 | 52.35 | 55.58 | 57.72 |
Other Long-Term Assets | 2.9 | 2.9 | 1.7 | 1.64 | 1.64 | 1.64 |
Total Assets | 333.59 | 551.33 | 487.72 | 646.59 | 461.19 | 543.1 |
Accounts Payable | 5.65 | 12.46 | 2.58 | 5.36 | 3.73 | 2.36 |
Accrued Expenses | 40.37 | 45.92 | 33.98 | 24.7 | 13.39 | 8.74 |
Current Portion of Leases | 4.08 | 3.98 | 3.88 | 3.76 | 3.63 | 3.46 |
Total Current Liabilities | 50.09 | 62.36 | 40.44 | 33.83 | 20.76 | 14.55 |
Long-Term Debt | 47.63 | 46.38 | 44.81 | 28.65 | - | - |
Long-Term Leases | 24.64 | 25.81 | 27.18 | 28.35 | 29.21 | 29.82 |
Other Long-Term Liabilities | 0.69 | 0.94 | 0.79 | 0.47 | - | - |
Total Long-Term Liabilities | 72.96 | 73.12 | 72.78 | 57.47 | 29.21 | 29.82 |
Total Liabilities | 123.05 | 135.49 | 113.21 | 91.3 | 49.96 | 44.37 |
Common Stock | 0.08 | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 |
Additional Paid-in Capital | 1,394 | 1,359 | 1,071 | 1,035 | 723.36 | 692.24 |
Accumulated Other Comprehensive Income | 5.56 | 5.45 | 4.86 | 5.73 | -0.97 | -0.39 |
Retained Earnings | -1,189 | -948.58 | -701.28 | -485.49 | -311.2 | -193.17 |
Shareholders' Equity | 210.54 | 415.84 | 374.51 | 555.29 | 411.23 | 498.73 |
Total Liabilities & Equity | 333.59 | 551.33 | 487.72 | 646.59 | 461.19 | 543.1 |
Total Debt | 76.35 | 76.17 | 75.87 | 60.76 | 32.84 | 33.28 |
Net Cash (Debt) | 192.79 | 407.64 | 344.8 | 522.63 | 362.82 | 443.02 |
Net Cash Growth | -52.70% | 18.22% | -34.03% | 44.05% | -18.10% | 249.48% |
Net Cash Per Share | 2.10 | 5.06 | 5.18 | 8.98 | 6.95 | 9.58 |
Book Value | 210.54 | 415.84 | 374.51 | 555.29 | 411.23 | 498.73 |
Book Value Per Share | 2.30 | 5.16 | 5.63 | 9.54 | 7.88 | 10.78 |
Tangible Book Value | 210.54 | 415.84 | 374.51 | 555.29 | 411.23 | 498.73 |
Tangible Book Value Per Share | 2.30 | 5.16 | 5.63 | 9.54 | 7.88 | 10.78 |